Literature DB >> 21240729

Determining when enhanced pause (Penh) is sensitive to changes in specific airway resistance.

David G Frazer1, Jeffrey S Reynolds, Mark C Jackson.   

Abstract

Penh is a dimensionless index normally used to evaluate changes in the shape of the airflow pattern entering and leaving a whole-body flow plethysmograph as an animal breathes. The index is sensitive to changes in the distribution of area under the waveform during exhalation and increases in a nonlinear fashion as the normalized area increases near the beginning of the curve. Enhanced pause (Penh) has been used to evaluate changes in pulmonary function and as a method to evaluate airway reactivity. However, the use of Penh to assess pulmonary function has been challenged (Bates et al., 2004; Lundblad et al., 2002; Mitzner et al., 2003; Mitzner & Tankersley, 1998; Petak et al., 2001; Sly et al., 2005). The objective of this study was to show how Penh of the thorax and plethysmograph flow patterns are related. That relationship is used to describe the conditions under which whole-body plethysmograph Penh measurements can be used to detect changes in sRaw.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21240729     DOI: 10.1080/15287394.2010.514235

Source DB:  PubMed          Journal:  J Toxicol Environ Health A        ISSN: 0098-4108


  5 in total

Review 1.  Phosgene-induced acute lung injury (ALI): differences from chlorine-induced ALI and attempts to translate toxicology to clinical medicine.

Authors:  Wenli Li; Juergen Pauluhn
Journal:  Clin Transl Med       Date:  2017-06-02

2.  Cellular senescence mediates fibrotic pulmonary disease.

Authors:  Marissa J Schafer; Thomas A White; Koji Iijima; Andrew J Haak; Giovanni Ligresti; Elizabeth J Atkinson; Ann L Oberg; Jodie Birch; Hanna Salmonowicz; Yi Zhu; Daniel L Mazula; Robert W Brooks; Heike Fuhrmann-Stroissnigg; Tamar Pirtskhalava; Y S Prakash; Tamara Tchkonia; Paul D Robbins; Marie Christine Aubry; João F Passos; James L Kirkland; Daniel J Tschumperlin; Hirohito Kita; Nathan K LeBrasseur
Journal:  Nat Commun       Date:  2017-02-23       Impact factor: 14.919

3.  Glucagon-Like Peptide 1 and Atrial Natriuretic Peptide in a Female Mouse Model of Obstructive Pulmonary Disease.

Authors:  Emilie Balk-Møller; Johanne Agerlin Windeløv; Berit Svendsen; Jenna Hunt; Seyed Mojtaba Ghiasi; Charlotte Mehlin Sørensen; Jens Juul Holst; Hannelouise Kissow
Journal:  J Endocr Soc       Date:  2019-12-19

4.  Respiratory Effects of Treatment with a Glucagon-Like Peptide-1 Receptor Agonist in Patients Suffering from Obesity and Chronic Obstructive Pulmonary Disease.

Authors:  Ayse Dudu Altintas Dogan; Ole Hilberg; Søren Hess; Torben Tranborg Jensen; Else-Marie Bladbjerg; Claus Bogh Juhl
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-02-22

5.  Measurement of airway function using invasive and non-invasive methods in mild and severe models for allergic airway inflammation in mice.

Authors:  Kim A T Verheijden; Paul A J Henricks; Frank A Redegeld; Johan Garssen; Gert Folkerts
Journal:  Front Pharmacol       Date:  2014-08-12       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.